Skip to menu Skip to content Skip to footer
Dr Eduardo Albornoz Balmaceda
Dr

Eduardo Albornoz Balmaceda

Email: 

Overview

Background

Dr. Albornoz is an early career researcher who has training in neuroscience, immunology, and pharmacology. Prior to migrating to Australia, he completed a bachelor's in Biochemistry followed by a master’s degree in Chile, he then gained experience working in Chile as a research assistant in the Millennium Institute for Immunology and Immunotherapy, focusing on neurodegeneration and the immune response in the context of Multiple Sclerosis. Later, he was awarded a UQ international scholarship to undertake a Ph.D. at the Institute for Molecular Biosciences (IMB), under the supervision of Prof Matt Cooper, his Ph.D. project has assisted in the development of next-generation NLRP3 inflammasome inhibitors, and to validate NLRP3 as a druggable therapeutic target for Parkinson’s disease. He completed his Ph.D. in 2019 and continued his post-doctoral research studies under the supervision of Prof Trent Woodruff. A key focus of his current work is testing novel drugs in preclinical models and understanding the role of the peripheral innate immune response in neurodegenerative diseases including motor neuron disease (amyotrophic lateral sclerosis), Huntington's disease, and Parkinson's disease.

Availability

Dr Eduardo Albornoz Balmaceda is:
Available for supervision
Media expert

Qualifications

  • Masters (Research) of Biochemistry, Universidad Andrés Bello
  • Doctor of Philosophy of Neurosciences, The University of Queensland

Works

Search Professor Eduardo Albornoz Balmaceda’s works on UQ eSpace

22 works between 2013 and 2023

1 - 20 of 22 works

2023

Journal Article

Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology

Aguado, Julio, Amarilla, Alberto A., Taherian Fard, Atefeh, Albornoz, Eduardo A., Tyshkovskiy, Alexander, Schwabenland, Marius, Chaggar, Harman K., Modhiran, Naphak, Gómez-Inclán, Cecilia, Javed, Ibrahim, Baradar, Alireza A., Liang, Benjamin, Peng, Lianli, Dharmaratne, Malindrie, Pietrogrande, Giovanni, Padmanabhan, Pranesh, Freney, Morgan E., Parry, Rhys, Sng, Julian D. J., Isaacs, Ariel, Khromykh, Alexander A., Valenzuela Nieto, Guillermo, Rojas-Fernandez, Alejandro, Davis, Thomas P., Prinz, Marco, Bengsch, Bertram, Gladyshev, Vadim N., Woodruff, Trent M., Mar, Jessica C. ... Wolvetang, Ernst J. (2023). Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology. Nature Aging, 3 (12), 1561-1575. doi: 10.1038/s43587-023-00519-6

Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology

2023

Journal Article

200 Complement drives Parkinson’s disease neuropathology through activation of microglial C5a receptors

Albornoz, Eduardo and Woodruff, Trent (2023). 200 Complement drives Parkinson’s disease neuropathology through activation of microglial C5a receptors. Immunobiology, 228 (5) 152650, 1-1. doi: 10.1016/j.imbio.2023.152650

200 Complement drives Parkinson’s disease neuropathology through activation of microglial C5a receptors

2023

Journal Article

Response to comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”

Albornoz, Eduardo A., Gordon, Richard, Kumar, Vinod, Robertson, Avril A. B., Schroder, Kate and Woodruff, Trent M. (2023). Response to comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”. Science Translational Medicine, 15 (696) adh0604, 1-4. doi: 10.1126/scitranslmed.adh0604

Response to comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”

2023

Journal Article

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

Albornoz, Eduardo A., Amarilla, Alberto A., Modhiran, Naphak, Parker, Sandra, Li, Xaria X., Wijesundara, Danushka K., Aguado, Julio, Zamora, Adriana Pliego, McMillan, Christopher L. D., Liang, Benjamin, Peng, Nias Y. G., Sng, Julian D. J., Saima, Fatema Tuj, Fung, Jenny N., Lee, John D., Paramitha, Devina, Parry, Rhys, Avumegah, Michael S., Isaacs, Ariel, Lo, Martin W., Miranda-Chacon, Zaray, Bradshaw, Daniella, Salinas-Rebolledo, Constanza, Rajapakse, Niwanthi W., Wolvetang, Ernst J., Munro, Trent P., Rojas-Fernandez, Alejandro, Young, Paul R., Stacey, Katryn J. ... Woodruff, Trent M. (2023). SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Molecular Psychiatry, 28 (7), 2878-2893. doi: 10.1038/s41380-022-01831-0

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

2022

Journal Article

SARS-CoV-2 triggers complement activation through interactions with heparan sulfate

Lo, Martin W., Amarilla, Alberto A., Lee, John D., Albornoz, Eduardo A., Modhiran, Naphak, Clark, Richard J., Ferro, Vito, Chhabra, Mohit, Khromykh, Alexander A., Watterson, Daniel and Woodruff, Trent M. (2022). SARS-CoV-2 triggers complement activation through interactions with heparan sulfate. Clinical and Translational Immunology, 11 (8) e1413, e1413. doi: 10.1002/cti2.1413

SARS-CoV-2 triggers complement activation through interactions with heparan sulfate

2022

Journal Article

Nucleocapsid specific diagnostics for the detection of divergent SARS-CoV-2 variants

Isaacs, Ariel, Amarilla, Alberto A., Aguado, Julio, Modhiran, Naphak, Albornoz, Eduardo A., Baradar, Alireza A., McMillan, Christopher L. D., Choo, Jovin J. Y., Idris, Adi, Supramaniam, Aroon, McMillan, Nigel A. J., Muller, David A., Young, Paul R., Woodruff, Trent M., Wolvetang, Ernst J., Chappell, Keith J. and Watterson, Daniel (2022). Nucleocapsid specific diagnostics for the detection of divergent SARS-CoV-2 variants. Frontiers in Immunology, 13 926262, 926262. doi: 10.3389/fimmu.2022.926262

Nucleocapsid specific diagnostics for the detection of divergent SARS-CoV-2 variants

2020

Journal Article

The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins

Deora, Vandana, Lee, John D., Albornoz, Eduardo A., McAlary, Luke, Jagaraj, Cyril J., Robertson, Avril A. B., Atkin, Julie D, Cooper, Matthew A., Schroder, Kate, Yerbury, Justin J., Gordon, Richard and Woodruff, Trent M. (2020). The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia, 68 (2) glia.23728, 407-421. doi: 10.1002/glia.23728

The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins

2019

Other Outputs

Pharmacological targeting of the inflammasome: towards novel therapeutics for Parkinson’s disease

Albornoz Balmaceda, Eduardo (2019). Pharmacological targeting of the inflammasome: towards novel therapeutics for Parkinson’s disease. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/uql.2019.702

Pharmacological targeting of the inflammasome: towards novel therapeutics for Parkinson’s disease

Featured

2018

Journal Article

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

Gordon, Richard, Albornoz, Eduardo A., Christie, Daniel C., Langley, Monica R., Kumar, Vinod, Mantovani, Susanna, Robertson, Avril A. B., Butler, Mark S., Rowe, Dominic B., O'Neill, Luke A., Kanthasamy, Anumantha G., Schroder, Kate, Cooper, Matthew A. and Woodruff, Trent M. (2018). Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice. Science Translational Medicine, 10 (465) aah4066, eaah4066. doi: 10.1126/scitranslmed.aah4066

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

2018

Journal Article

Gestational hypothyroxinemia affects its offspring with a reduced suppressive capacity impairing the outcome of the experimental autoimmune encephalomyelitis

Haensgen, Henny, Albornoz, Eduardo, Opazo, María C., Bugueño, Katherinne, Jara Fernández, Evelyn Liliana, Binzberger, Rebecca, Rivero-Castillo, Tomás, Venegas Salas, Luis F., Simon, Felipe, Cabello-Verrugio, Claudio, Elorza, Alvaro A., Kalergis, Alexis M., Bueno, Susan M. and Riedel, Claudia A. (2018). Gestational hypothyroxinemia affects its offspring with a reduced suppressive capacity impairing the outcome of the experimental autoimmune encephalomyelitis. Frontiers in Immunology, 9 (JUN) 1257. doi: 10.3389/fimmu.2018.01257

Gestational hypothyroxinemia affects its offspring with a reduced suppressive capacity impairing the outcome of the experimental autoimmune encephalomyelitis

2018

Journal Article

Gestational hypothyroxinemia imprints a switch in the capacity of astrocytes and microglial cells of the offspring to react in inflammation

Opazo, María C., González, Pablo A., Flores, Betsi D., Venegas, Luis F., Albornoz, Eduardo A., Cisternas, Pablo, Bohmwald, Karen, Nieto, Pamela A., Bueno, Susan M., Kalergis, Alexis M. and Riedel, Claudia A. (2018). Gestational hypothyroxinemia imprints a switch in the capacity of astrocytes and microglial cells of the offspring to react in inflammation. Molecular Neurobiology, 55 (5), 4373-4387. doi: 10.1007/s12035-017-0627-y

Gestational hypothyroxinemia imprints a switch in the capacity of astrocytes and microglial cells of the offspring to react in inflammation

2018

Journal Article

Chronic helminth infection perturbs the gut-brain axis, promotes neuropathology and alters behaviour

Giacomin, Paul R., Kraeuter, Ann Katrin, Albornoz, Eduardo A., Jin, Shuting, Bengtsson, Mia, Gordon, Richard, Woodruff, Trent M., Urich, Tim, Sarnyai, Zoltán and Soares Magalhães, Ricardo J. (2018). Chronic helminth infection perturbs the gut-brain axis, promotes neuropathology and alters behaviour. The Journal of Infectious Diseases, 218 (9), 1511-1516. doi: 10.1093/infdis/jiy092

Chronic helminth infection perturbs the gut-brain axis, promotes neuropathology and alters behaviour

2018

Conference Publication

C5aR1 is required for a-synuclein mediated NLRP3 inflammasome activation

Gordon, Richard, Albornoz, Eduardo, Kanthasamy, Anumantha and Woodruff, Trent (2018). C5aR1 is required for a-synuclein mediated NLRP3 inflammasome activation. 27th International Complement Workshop (ICW), Santa Fe, NM, United States, Sep 16-20, 2018. Kidlington, Oxford, United Kingdom: Pergamon Press. doi: 10.1016/j.molimm.2018.06.247

C5aR1 is required for a-synuclein mediated NLRP3 inflammasome activation

2018

Book Chapter

Inflammasomes in CNS diseases

Albornoz, Eduardo A., Woodruff, Trent M. and Gordon, Richard (2018). Inflammasomes in CNS diseases. Inflammasomes: clinical and therapeutic implications. (pp. 41-60) edited by Mario D. Cordero and Elisabet Alcocer-Gómez. Cham, Switzerland: Springer International. doi: 10.1007/978-3-319-89390-7_3

Inflammasomes in CNS diseases

2017

Journal Article

The ketone body β-hydroxybutyrate does not inhibit synuclein mediated inflammasome activation in microglia

Deora, Vandana, Albornoz, Eduardo A., Zhu, Kevin, Woodruff, Trent M. and Gordon, Richard (2017). The ketone body β-hydroxybutyrate does not inhibit synuclein mediated inflammasome activation in microglia. Journal of Neuroimmune Pharmacology, 12 (4), 1-7. doi: 10.1007/s11481-017-9754-5

The ketone body β-hydroxybutyrate does not inhibit synuclein mediated inflammasome activation in microglia

2017

Conference Publication

Gestational hypothyroxinemia increases the immune response of the progeny that suffers experimental autoimmune encephalomyelitis

Opazo, Maria Cecilia, Bugueño, Katherinne, Jara, Evelyn, Haensgen, Henny, Albornoz, Eduardo, Gomez, Felipe, Binzberger, Rebecca, Toledo, Paola, Blanco, Noelia, Simon, Felipe, Elorza, Alvaro, Kalergis, Alexis, Bueno, Susan and Riedel, Claudia (2017). Gestational hypothyroxinemia increases the immune response of the progeny that suffers experimental autoimmune encephalomyelitis. Immunology 2017™ Meeting, Washington, DC United States, 12-16 May 2017. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.198.supp.207.8

Gestational hypothyroxinemia increases the immune response of the progeny that suffers experimental autoimmune encephalomyelitis

2017

Conference Publication

Gut microbiome changes induced by experimental trichuris muris infection are associated with decreased cognitive function in mice

Magalhaes, Ricardo J. Soares, Giacomin, Paul, Sarnyay, Zoltan, Kraeuter, Ann, Urich, Tim, Bengtsson, Mia, Jin, Shuting, Albornoz, Eduardo A., Gordon, Richard and Woodruff, Trent (2017). Gut microbiome changes induced by experimental trichuris muris infection are associated with decreased cognitive function in mice. 65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH), Atlanta, GA, United States, 13-16 November 2016. Deerfield, United States: American Society of Tropical Medicine and Hygiene.

Gut microbiome changes induced by experimental trichuris muris infection are associated with decreased cognitive function in mice

2016

Conference Publication

Complement C5a activates microglial NLRP3 inflammasomes and drives neurodegeneration in Parkinson's disease through C5aR1

Gordon, Richard, Albornoz, Eduardo A., Kumar, Vinod, Zhou, Kiane, Garin-Michaud, Ashoka, Mantavani, Susanna, Kanthasamy, Anumantha G. and Woodruff, Trent M. (2016). Complement C5a activates microglial NLRP3 inflammasomes and drives neurodegeneration in Parkinson's disease through C5aR1. The XXVI International Complement Workshop (ICW), Kanazawa, Japan, 4-8 September 2016. Muenchen, Germany: Elsevier. doi: 10.1016/j.imbio.2016.06.146

Complement C5a activates microglial NLRP3 inflammasomes and drives neurodegeneration in Parkinson's disease through C5aR1

2015

Journal Article

Gestational hypothyroidism increases the severity of experimental autoimmune encephalomyelitis in adult offspring (vol 23, pg 1627, 2013)

Albornoz, E. A., Carreno, L. J., Cortes, C. M., Gonzalez, P. A., Cisternas, P. A., Cautivo, K. M., Catalan, T. P., Opazo, M. C., Eugenin, E. A., Berman, J. W., Bueno, S. M., Kalergis, A. M. and Riedel, C. A. (2015). Gestational hypothyroidism increases the severity of experimental autoimmune encephalomyelitis in adult offspring (vol 23, pg 1627, 2013). Thyroid, 25 (9), 1068-1068. doi: 10.1089/thy.2012.0401.cxn

Gestational hypothyroidism increases the severity of experimental autoimmune encephalomyelitis in adult offspring (vol 23, pg 1627, 2013)

2015

Journal Article

Excess iodide induces an acute inhibition of the sodium/iodide symporter in thyroid male rat cells by increasing reactive oxygen species

Arriagada, Alejandro A., Albornoz, Eduardo, Cecilia Opazo, Ma., Becerra, Alvaro, Vidal, Gonzalo, Fardella, Carlos, Michea, Luis, Carrasco, Nancy, Simon, Felipe, Elorza, Alvaro A., Bueno, Susan M., Kalergis, Alexis M. and Riedel, Claudia A. (2015). Excess iodide induces an acute inhibition of the sodium/iodide symporter in thyroid male rat cells by increasing reactive oxygen species. Endocrinology, 156 (4), 1540-1551. doi: 10.1210/en.2014-1371

Excess iodide induces an acute inhibition of the sodium/iodide symporter in thyroid male rat cells by increasing reactive oxygen species

Funding

Past funding

  • 2023 - 2024
    C9orf72 dipeptide-mediated activation of microglia as a therapeutic target for MND
    Motor Neurone Disease Research Institute of Australia Inc Innovator Grant
    Open grant
  • 2020 - 2021
    Inflammatory biomarkers in 6-OHDA mouse model of Parkinson's disease
    UniQuest Pty Ltd
    Open grant

Supervision

Availability

Dr Eduardo Albornoz Balmaceda is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Therapeutic blockade of neuroinflammation for the treatment of Huntington's disease

    Associate Advisor

    Other advisors: Dr John Lee, Professor Trent Woodruff

Media

Enquiries

Contact Dr Eduardo Albornoz Balmaceda directly for media enquiries about:

  • C5aR
  • Complement system
  • Drug discovery
  • Immunology
  • Infectious disease and brain
  • Inflammasomes
  • Long COVID
  • Microglia
  • Neuroimmunology
  • Neuroinflammation
  • Neuroscience
  • NLRP3
  • Parkinson's disease

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au